Novel Long-Acting Injection Cuts Schizophrenia Relapse

A novel risperidone formulation cuts relapse risk in schizophrenia, new research suggests; but experts wonder: will it help improve the field's "deplorably low" use of long-acting antipsychotics?
Medscape Medical News